Syphilis is a sexually transmitted disease of considerable public health importance that poses a great threat to patients when not properly diagnosed and treated. After inoculation, a primary lesion associated with regional lymphadenopathy is noted. A secondary bacteremic stage with mucocutaneous manifestations is followed by a latent period of subclinical infection. In about onethird of untreated cases, a tertiary stage characterized by destructive skin, mucous, or skeletal lesions, aortitis, and central nervous system disease appears [1] . Treponema pallidum, the pathogenic agent of syphilis, can be treated easily and inexpensively with antibiotics, which also are the most useful way for preventing its spread [1, 2] .
Re-emergence of syphilis, a disease previously believed to be close to eradication, is a matter of increasing global concern [3, 4] . The incidence of syphilis has been rising in western countries since the year 2000, after having decreased to a historical minimum in the early 1990s [5] . Social changes regarding prostitution, sex tourism, the use of Internet for finding sporadic sex partners, and the decreasing use of barrier contraceptive methods have been proposed as possible causes for the re-emergence of syphilis [5] . Cases in men who have sex with men (MSM) and human immunodeficiency virus (HIV)-infected persons account for most of the recent increase in syphilis prevalence in Europe and the United States. Factors such as the comfort and sense of false security caused by taking antiretroviral drugs, as well as the increasing use of crystal methamphetamine and drugs to treat erectile dysfunction among MSM, have been suggested to be the main causes for the increasing prevalence of syphilis in this population [3] [4] [5] [6] [7] [8] .
Infection with HIV may affect both the natural course of syphilis and the response to treatment. Some previous studies have found a greater number of serological failures after treatment and a greater risk of developing complications, particularly neurosyphilis, among HIV-positive MSM [9] [10] [11] [12] . Therefore, a closer follow-up is recommended for HIV-positive persons with syphilis [13] . The aims of our study were to describe the recent changes in the epidemiology and clinical features of syphilis in Madrid and to assess the factors that may determine serologic response to treatment.
PATIENTS AND METHODS

Data recovery and definitions.
We reviewed the cases of all patients with syphilis who were enrolled in a longitudinal study from January 2003 through December 2007 at the Fundació n Jiménez Díaz, a tertiary referral hospital affiliated to the Universidad Autó noma de Madrid that provides service for a population of 300,000 people in downtown Madrid. All patients with active syphilis who were not previously treated and had positive nontreponemal test results confirmed by treponemal tests or dark field microscopy were included in the study. Patients with congenital syphilis, patients with syphilis that was previously treated, and those with primary syphilis with nonreactive reaginic tests were excluded.
Disease stage was classified as early when the patient presented with primary, secondary, or early latent syphilis. A patient was considered to be in the early latent stage when signs of primary or secondary syphilis occurred within a year before diagnosis. The disease stage was classified as late for patients with tertiary syphilis and those with syphilis of unknown duration.
Patients were diagnosed with symptomatic neurosyphilis if they had positive syphilis serology and an otherwise unexplained neurological finding (meningitis, brain infarct, or cranial nerve paralysis) with or without abnormal cerebrospinal fluid results on lumbar puncture (pleocytosis [white blood cell count 110 cells/mL], protein level 150 mg/dL, and reactive venereal diseases research laboratory result). Cerebrospinal fluid samples were not routinely examined. However, in HIV-positive patients who did not exhibit serologic response and who had rapid plasma reagin (RPR) titers у1:32 at 3 or 6 months after penicillin treatment, a lumbar puncture was performed. Uveitis was diagnosed by means of ophthalmoscopic examination.
Rheumatologic complications (periostitis and osteitis) were diagnosed by means of clinical examination and computed tomography scan.
Measurements. RPR and the microhemagglutination assay for antibodies to T. pallidum were performed following recommendations for the laboratory diagnosis of syphilis by Larsen et al [14] . HIV serology, CD4 + T cell count, and determination of viral load were assessed by conventional procedures [15] . RPR tests were performed at the time of diagnosis and were scheduled at 3-month intervals after treatment.
Definition of serologic failure. Serologic failure was defined as a lack of a 4-fold decrease-2 dilutions-in RPR titers at 13 months after treatment (eg, from 1:32 to 1:8) or a 4-fold increase in RPR titers у30 days after treatment. Because other reports have shown that many patients do not return for timely follow-up in serologic studies [10, 16, 17] , we used a 13-month cut-off in an attempt to capture most patients for their 1-year follow-up serologic testing. Patients whose RPR titers decreased after treatment and subsequently increased 4-fold were deemed to be reinfected and were excluded from the analysis of serologic response. Time to serologic response was measured as the time from administration of treatment to the first day when serologic response was detected.
Data analysis. Data were introduced twice into a computerized database. Discordant pieces of data were corrected 1 by 1 on the basis of the original information.
Qualitative variables were expressed as percentages. Quantitative variables were expressed as mean values ‫ע(‬ standard deviation [SD]) if they followed a normal distribution or as median values (interquartile range) if they did not. Association was tested with x 2 test or with Fisher's exact test when necessary. The strength of associations was measured with either a hazard ratio (HR) or an odds ratio (OR), with 95% confidence intervals (95% CIs).
Differences between 2 means were tested with the independent samples T test, and comparisons among 12 mean values were tested with a 1-factor analysis of the variance, when normality and homocedasticity conditions allowed it. When analysis of variance was not possible, the Mann-Whitney test for 2 independent samples or the Kruskal-Wallis test for k-independent samples were performed. Post hoc analysis of analysis of variance results was performed with Tuckey-Kramer test. Differences between 2 means were measured with Cohen's D statistic and its 95% CI.
Bivariate analysis of time to detection of serological response to treatment was performed through the study of Kaplan-Meier curves and analysis with the Breslow test. Multivariate analysis was performed with Cox proportional hazards models, after confirming the proportional risks assumption through the analysis of Schoenfeld residuals. All patients with at least 2 RPR results were entered in the model. The selection of variables in the final model was performed by a forward-conditional method, with significance levels of р.05 for inclusion and у.1 for exclusion. Cox-Snell residuals were used to assess the overall model fit. Data were analyzed using SPSS, version 16.0 (SPSS), and Stata/SE, version 10.0 (StataCorp).
RESULTS
Four hundred twelve patients with syphilis were seen during the study period. Sixty-three patients who were already treated, who had primary syphilis with nonreactive RPR tests, or who had neonatal syphilis ( ) were excluded from further analn p 2 ysis. Therefore, 347 patients with active syphilis constitute the group herein analyzed. Figure 1 shows the incidence of syphilis from 2003 through 2007. A 223% increase in syphilis incidence was observed (from 15.67 to 35 cases per 100,000 persons per year). Table 1 summarizes the most relevant clinical findings of this series: 85.4% of patients were men (ratio of male to female patients, 6:1), of whom 51.7% were MSM; 41.5% of patients were not native Spaniards (29.2% from South America or the Caribbean, 6.3% from the European Union, 2.6% from Africa, 2.3% from Eastern Europe, and 0.3% from Asia). The mean age ‫ע(‬ SD) was years, and age was significantly 39.37 ‫ע‬ 12.9 higher among patients with late syphilis. Forty-nine percent of all patients had received a diagnosis of HIV infection before the development of syphylis.
Most patients (47.3%) presented with secondary syphilis. Noteworthy, 25% of patients with clinical signs of secondary syphilis still had a genital or oral chancre in different stages of evolution. HIV-positive patients had coincidental chancre and rash more frequently than HIV-negative individuals (25 of 184 vs 16 of 163 patients; OR, 1.45; 95% CI, 0.84-2.81). Among patients with late syphilis, 10 (2.8%) had tertiary syphilis. Eight patients received a diagnosis of meningovascular syphilis, and 2 had gummatous osteomyelitis. Table 2 shows some epidemiologic, clinical, and laboratory findings for cases of syphilis in HIV-positive and HIV-negative individuals. HIV-positive patients were younger, more frequently were men, and presented with secondary syphilis more frequently than HIV-negative persons. In addition, they had higher RPR titers ( ). We did not find that complications P ! .001 occurred significantly more often in the HIV-positive than in HIV-negative groups (Table 2) .
Eighty-seven percent of the patients were treated with 1-3 intramuscular doses of international units of benza- 6 2.4 ϫ 10 thine penicillin G given weekly. In addition, 6.7% of the patients who had neurosyphilis or were pregnant women were treated intravenously with crystalline penicillin G over 10-14 days. Eleven percent of patients received an alternative treatment with oral doxycycline (100 mg every 12 h) over 3 weeks. Most of these patients had a history of penicillin allergy.
Two patients died during follow-up because of causes other Figure 2 shows the time to detection of serologic response to treatment in both HIV-positive and HIV-negative groups. This time was significantly longer among the HIV-infected patients ( , by Breslow test). Although HIV-negative pa-P p .001 tients responded more frequently to treatment during most of the follow-up, it seemed that in the long term (after 2 years of follow-up), both groups shared similar response rates. Seroreversion was infrequent, and RPR titers р1:16 persisted in 84.6% and 20% HIV-positive and HIV-negative individuals, respectively, after 400 days (OR, 22; 95% CI, 2.1-232).
To assess the possible interaction of variables heterogeneously distributed between the 2 groups, a Cox proportional hazards model was created. Age, sex, RPR baseline titer, disease stage, antibiotic treatment (penicillin G vs doxycycline), number of penicillin doses (1 vs 3), HIV status, and levels of platelets and leukocytes in blood were included as possible predictors of the time to response to treatment. Only sex, disease stage, and HIV status were predictors of the response. Multivariate analysis indicated that men (HR, 0.38), patients in the late stage of syphilis (HR, 0.46), and HIV-positive persons (HR, 0.61) demonstrated a slower serological response to treatment (Table 3 , model A).
To explain these findings and the slower response observed among HIV-positive persons, time to response was analyzed according to viral load, CD4 + T lymphocyte count, percent of CD4 + T cells, and the slope of increase in CD4 + T cells. Bivariate analysis did not find any significant difference between groups, even though a trend to a slower response was observed among those with greater viral loads and lower CD4 + T cell counts. A new Cox model, including viral load, CD4 + T cell count, and antiviral treatment as possible predictors, was created (Table 3, model B). Antiretroviral treatment was the single variable that significantly reduced the time to serologic response (HR, 2.08; 95% CI, 1.35-3.20;
). P p .001
DISCUSSION
Our study confirms the rapid increasing trend of syphilis in Madrid, which has happened before in other large European and American cities, particularly among MSM, people infected with HIV, and immigrants [3, 4, 11] . The increased ratio of male to female patients observed in this series was probably a reflection of the disproportionate burden of disease among MSM, but considering the high number of patients self-identified as being heterosexual, it is tempting to speculate that the diagnosis may be missed in a high proportion of women.
Another alarming observation was the fact that 53% of the patients were coinfected with the HIV, and most were aware of their HIV status before the onset of syphilis. These persons had not modified their sexual habits despite of the risk of acquiring other sexually transmitted diseases and of transmitting HIV to other individuals [6] . This behavior may cause an increase in the incidence of HIV infection, as has occurred with other sexually transmitted diseases such as gonorrhoea and lymphogranuloma venereum, together with an enormous pressure on the health care systems [3, 6, 18, 19] . In addition, the occurrence of cases of gummatous osteitis and meningovascular syphilis in this series suggests the emergence of severe complications of tertiary syphilis among people who are currently being infected but not diagnosed or treated in the years to come.
Some reports have shown an increased risk of neurosyphilis in patients coinfected with HIV [11, 20] . However, in our series, in which the estimated risk for having symptomatic early neurosyphilis was even higher than that estimated by others [11, 21], we did not find an increased frequency of this or other complications among HIV-infected patients when compared with HIV-negative persons. Similar data have been reported elsewhere [22] . However, because cerebrospinal fluid samples were not routinely examined and only HIV-positive patients with serologic failure and persistent RPR titers у1:32 were selected for lumbar puncture, it is possible that diagnosis of silent neurosyphilis could have been missed in some cases.
As shown by others [10] , we did observe a higher number of serologic failures among HIV-positive patients, compared with HIV-negative individuals. This observation may have some important clinical implications.
In the pre-AIDS penicillin era, documented serologic failures to syphilis treatment were exceedingly rare. A 4-fold decrease in RPR titers by the third or fourth month and an 8-fold decrease in titers by the sixth to eight month was observed, and for most patients treated for early syphilis, seroreversion was documented after the first year [14, 23] . Clearly, this is not the case in HIV-infected patients. This investigation showed that HIV infection was associated with a slower serologic response to syphilis treatment. Time to response was significantly longer among HIV-infected patients, and these patients were less likely to experience serologic improvement after recommended therapy than were HIV-negative persons [12] . Low RPR titers persisted in most HIV-positive patients at 1 year after treatment, but as far as can be determined, this persistent seropositivity did not signify treatment failure or reinfection. Specifically, these patients were carefully followed up, lumbar puncture performed in those with RPR titers 11:32 did not show abnormalities, and at the time of writing, all of them remain asymptomatic.
Analysis of the serologic response to treatment in our cohort showed that men and patients with late syphilis exhibited a slow response to treatment. This more gradual decrease in RPR titers in patients with late stages of syphilis has been observed by others [24] . However, to the best of our knowledge, this is the first study to detect an influence of sex on the time to serologic response to syphilis treatment. The significance of this observation is unknown at the present time.
In contrast to other reports, neither the initial RPR titer nor the CD4 + lymphocyte cell count significantly influenced serologic response to therapy [12, 25] , although a trend toward a faster response in patients with lower viral loads and higher CD4 + T cell counts was observed. Remarkably, antiretroviral therapy was the single variable associated with a significant reduction of the time to serologic response in HIV-infected patients with syphilis. This fact suggests that immune restoration, viral suppression, or improved B lymphocyte functions may accelerate the decrease of RPR titers after treatment of syphilis. In agreement with these data, others have shown that antiretroviral therapy reduced the rate of serologic failures in HIV-positive patients, and that in the absence of antiretroviral therapy, serum RPR titers less accurately predicted treatment success in patients with neurosyphilis [25, 26] .
Our study has limitations. First, 32% of the HIV-positive and 62% of the HIV-negative patients were not followed up, a problem also found in other recent series [10, 16, 17] . HIVpositive patients had their RPR titers measured more frequently than HIV-negative patients. This fact could have led us to underestimate the time to serologic response to treatment in the HIV-negative group. Second, a large number of cases included in the late syphilis group involved individuals with syphilis of unknown duration. Although these patients were asymptomatic and did not show complications, it is possible that some actually had early syphilis.
Definition of serologic failure was arbitrary and similar to that used by others; we chose a cut-off value of 13 months to pick up a larger number of patients returning for 1-year followup tests [10] . However, taking into account the prolonged time needed to achieve serologic response, a shorter period of time would have been even less reliable to assess such response.
In summary, this study shows that an epidemic of syphilis is taking place in downtown Madrid, affecting mostly MSM, HIV-positive persons, and immigrants from South America and the Caribbeans. Men, patients in the late stages of syphilis, and HIV-positive persons may be at increased risk of serologic failure. Despite the recommendations for more frequent serological follow-up for HIV-positive patients with syphilis [13] , most patients did not have documentation of serologic response until the end of the first year after treatment. Testing at 3-4 months or even at 6 months, as recommended by guidelines, has a low efficiency, and only a minority of patients responded by that time. Therefore, early testing adds little benefit and may introduce a bias that leads to unnecessary retreatment. Low titers will persist in most HIV-positive patients 1 year after treatment. As far as can be determined, this persistent seropositivity does not signify treatment failure or reinfection.
